Allos Therapeutics, Inc. (ALTH) is at an implied volatility extreme high of 259.78% that is greater than 100.00% of past values prior to 6/2/2008 (Close Price 6.37). On prior close, 5/30/2008, the implied volatility was 69.63% and at the 14.18 percentile. Closing price was 6.34.
Today's News on Allos Therapeutics, Inc.
Today's News on Allos Therapeutics, Inc.
Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference (Business Wire)
WESTMINSTER, Colo.----Allos Therapeutics, Inc. , a
biopharmaceutical company focused on developing and
commercializing innovative small molecule drugs for the treatment
of cancer, today announced that members of the Company’s
senior management will present a corporate overview at the
NewsMakers in the Biotech Industry Conference, co-presented by
BioCentury and Thomson Reuters, in New York.
Stock Option Volatility Trading
A service of Trotter Trading Systems
Friday, Aug 29, 2008